Daniel Rosenbaum

464 total citations
12 papers, 272 citations indexed

About

Daniel Rosenbaum is a scholar working on Clinical Psychology, Organic Chemistry and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Daniel Rosenbaum has authored 12 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Clinical Psychology, 6 papers in Organic Chemistry and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Daniel Rosenbaum's work include Psychedelics and Drug Studies (8 papers), Chemical synthesis and alkaloids (6 papers) and Biochemical Analysis and Sensing Techniques (2 papers). Daniel Rosenbaum is often cited by papers focused on Psychedelics and Drug Studies (8 papers), Chemical synthesis and alkaloids (6 papers) and Biochemical Analysis and Sensing Techniques (2 papers). Daniel Rosenbaum collaborates with scholars based in Canada, United States and Switzerland. Daniel Rosenbaum's co-authors include Emma Hapke, Thomas Anderson, Lê-Anh Dinh-Williams, Katrina Hui, Rotem Petranker, Cory R. Weissman, Norman A. S. Farb, Daniel Z. Buchman, Andrew G. Lee and Setareh Ziai and has published in prestigious journals such as Psychopharmacology, The Canadian Journal of Psychiatry and Journal of Psychopharmacology.

In The Last Decade

Daniel Rosenbaum

11 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Rosenbaum Canada 6 247 179 79 44 37 12 272
Emma Hapke Canada 5 228 0.9× 168 0.9× 74 0.9× 44 1.0× 30 0.8× 5 244
Lê-Anh Dinh-Williams Canada 6 238 1.0× 167 0.9× 78 1.0× 45 1.0× 25 0.7× 10 259
L. Taylor Flynn United States 7 213 0.9× 158 0.9× 109 1.4× 29 0.7× 35 0.9× 9 264
Helena Aicher Switzerland 9 248 1.0× 139 0.8× 81 1.0× 60 1.4× 17 0.5× 21 274
Abigail E. Calder Switzerland 6 221 0.9× 130 0.7× 112 1.4× 21 0.5× 21 0.6× 10 244
Nathalie M. Rieser Switzerland 7 241 1.0× 177 1.0× 121 1.5× 17 0.4× 30 0.8× 10 290
Jordan Sloshower United States 8 301 1.2× 208 1.2× 124 1.6× 26 0.6× 48 1.3× 10 348
Timothy I. Michaels United States 9 374 1.5× 185 1.0× 112 1.4× 75 1.7× 50 1.4× 16 441
Taylor Lyons United Kingdom 7 272 1.1× 145 0.8× 124 1.6× 46 1.0× 20 0.5× 13 331
Erwin Krediet Netherlands 6 349 1.4× 196 1.1× 145 1.8× 44 1.0× 30 0.8× 7 413

Countries citing papers authored by Daniel Rosenbaum

Since Specialization
Citations

This map shows the geographic impact of Daniel Rosenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rosenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rosenbaum more than expected).

Fields of papers citing papers by Daniel Rosenbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rosenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rosenbaum. The network helps show where Daniel Rosenbaum may publish in the future.

Co-authorship network of co-authors of Daniel Rosenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Rosenbaum. A scholar is included among the top collaborators of Daniel Rosenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Rosenbaum. Daniel Rosenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rosenbaum, Daniel, et al.. (2025). The Use of Psychedelics for Grief Following Death due to Advanced Illness: A Scoping Review. OMEGA - Journal of Death and Dying. 4287641734–4287641734.
2.
Rosenbaum, Daniel, et al.. (2024). Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit Analysis. The Hastings Center Report. 54(4). 32–46. 6 indexed citations
3.
Levitt, Sarah, Daniel Rosenbaum, Kelli Stajduhar, et al.. (2024). Palliative psychiatry: research, clinical, and educational priorities. Annals of Palliative Medicine. 13(3). 542–557. 1 indexed citations
4.
Buchman, Daniel Z. & Daniel Rosenbaum. (2024). Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics. Public Health Ethics. 17(1-2). 24–39. 4 indexed citations
5.
Lee, Andrew G., Daniel Rosenbaum, & Daniel Z. Buchman. (2024). Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations. The Canadian Journal of Psychiatry. 69(5). 309–313. 8 indexed citations
6.
Green, Samantha, Daniel Rosenbaum, & Michaela Beder. (2023). Heat Resilience and Severe & Persistent Mental Illness. The Canadian Journal of Psychiatry. 69(4). 239–241. 1 indexed citations
7.
Rosenbaum, Daniel & Sarah Levitt. (2023). Mental Health and the Climate Crisis: A Call to Action for Canadian Psychiatrists. The Canadian Journal of Psychiatry. 68(11). 870–875. 5 indexed citations
8.
Rosenbaum, Daniel, Cory R. Weissman, Thomas Anderson, et al.. (2020). Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. Journal of Psychopharmacology. 34(6). 612–622. 40 indexed citations
9.
Anderson, Thomas, Rotem Petranker, Daniel Rosenbaum, et al.. (2019). Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology. 236(2). 731–740. 107 indexed citations
10.
Anderson, Thomas, Rotem Petranker, Daniel Rosenbaum, et al.. (2019). Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduction Journal. 16(1). 43–43. 83 indexed citations
11.
Rosenbaum, Daniel, et al.. (2019). Psychedelics for Psychological and Existential Distress in Palliative and Cancer Care. Current Oncology. 26(4). 225–226. 14 indexed citations
12.
Rosenbaum, Daniel, Daniel Merenstein, & Fremonta Meyer. (2002). Topical steroids more effective than antifungals for chronic paronychia.. PubMed. 51(10). 824–824. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma Hapke Breakdown of academic impact, for papers by Lê-Anh Dinh-Williams Breakdown of academic impact, for papers by L. Taylor Flynn Breakdown of academic impact, for papers by Helena Aicher Breakdown of academic impact, for papers by Abigail E. Calder Breakdown of academic impact, for papers by Nathalie M. Rieser Breakdown of academic impact, for papers by Jordan Sloshower Breakdown of academic impact, for papers by Timothy I. Michaels Breakdown of academic impact, for papers by Taylor Lyons Breakdown of academic impact, for papers by Erwin Krediet
Rankless by CCL
2026